-

Missfresh Limited Investigation: Robbins LLP is Investigating Missfresh Limited (MF) on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Missfresh Limited (NASDAQ: MF) and its officers and directors of to determine whether they breached fiduciary duties or violated securities laws in providing false financial figures in the Company's Registration Statement in support of its June 2021 initial public offering ("IPO"). Missfresh purports to be an innovator and leader in China's neighborhood retail industry, which invested the Distributed Mini Warehouse (DMW) model to operate an integrated online-and-offline on-demand retail business focusing on offering fresh produce and fast-moving consumer goods.

If you would like more information about our investigation of Missfresh Limited's misconduct, click here.

What is this Case About: According to the complaint filed against defendants, Missfresh held its IPO in June 2021, offering shares to the investing public at $13.00 per ADS.

On April 29, 2022, Missfresh filed with the SEC a Notification of Late Filing on Form 12b-25, which announced that it would be unable to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2021, by the prescribed filing deadline of April 30, 2022. Additionally, an independent Audit Committee of the Company's board of directors is conducting an internal review, including matters relating to transactions between the Company and certain third-party enterprises. On this news, Missfresh ADSs fell 23% to close at $0.448 per ADS on May 2, 2022.

Then, on May 24, 2022, Missfresh announced it had received a notification letter dated May 19, 2022, from the Listing Qualifications of NASDAQ indicating the Company is not in compliance with listing requirements. On this news, Missfresh ADSs fell 9% over two trading days, to close at $0.167 per ADS on May 26, 2022.

On July 1, 2022, Missfresh revealed it had substantially completed its review and "[a]s a result, certain revenue associated with these reporting periods in 2021 may have been inaccurately recorded in the Company's financial statements." The employees responsible for the questionable transactions were notified and given notices of resignation.

As of July 6, 2022, Missfresh’s ADSs closed at $0.3075, representing a 97% decline from the IPO price.

Next Steps: If you acquired shares of Missfresh Limited securities pursuant to the Company's IPO, you have legal options. Contact Robbins LLP for more information.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Missfresh Limited settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:MF

Release Summary
Robbins LLP is investigating Missfresh to determine whether it provided false financial figures in support of its June 2021 initial public offering
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Nektar Therapeutics Class Action Reminder – Robbins LLP Encourages NKTR Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Nektar Therapeutics (NASDAQ: NKTR) securities between February 26, 2025 and December 15, 2025. Nektar is a biopharmaceutical company focused on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders. The Company’s lead product candidate is rezpegaldesleukin, a novel, first-in-class regulat...

Robbins LLP Encourages SMCI Stockholders to Contact the Firm for Information About the Class Action Against Super Micro Computer, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Super Micro Computer, Inc. (NASDAQ: SMCI) securities between April 30, 2024 and March 19, 2026. Super Micro is a technology company that designs, develops, and manufactures high-performance server and storage systems, primarily for artificial intelligence (“AI”), data center, and cloud solutions customers.For more information, submit a form, em...

Robbins LLP Urges COTY Stockholders to Contact the Firm for Information About the Class Action Against Coty Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Coty Inc. (NYSE: COTY) common stock between November 5, 2025 and February 4, 2026. Coty together with its subsidiaries, manufactures, markets, distributes, and sells branded beauty products worldwide. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? November 5,...
Back to Newsroom